Interleukin-10 reduces hyperalgesia and the level of Interleukin-1β in BALB/c mice infected with Leishmania major with no major effect on the level of Interleukin-6

Journal of Neuroimmunology

Volumn 183, Issue 1-2, 2007, Pages 43-49

  Karam, Marc C ^a   Hamdan, Hamdan G ^a   Abi Chedid, Najib A ^a   Bodman Smith, Kikki B ^b   Baroody, George M ^a  

^a LEBANESE AMERICAN UNIVERSITY   (Lebanon)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Hyperalgesia; Immunoassays; Interleukins; Leishmania major; Pain tests

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; FEMALE; HYPERALGESIA; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANALYSIS OF VARIANCE; ANIMALS; FEMALE; HYPERALGESIA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; REACTION TIME;

EID: 33846811469     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.11.003     Document Type: Article

References (41)

1. Chessell I.P., Hatcher J.P., Bountra C., Michel A.D., Hughes J.P., Green P., Egerton J., Murfin M., Richardson J., Peck W.L., Grahames C.B., Casula M.A., Yiangou Y., Birch R., Anand P., and Buell G.N. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114 3 (2005) 386-396
2. Choi H.S., Ju J.S., Lee H.J., Kim B.C., Park J.S., and Ahn D.K. Effects of intracisternal injection of interleukin-6 on nociceptive jaw opening reflex and orofacial formalin test in freely moving rats. Brain Res. Bull. 59 (2003) 365-370
3. Corry D.B., Reiner S.L., Linsley P.S., and Locksley R.M. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153 (1994) 4142-4148
4. Cunha F.Q., Lorenzetti B.B., Poole S., and Ferreira S.H. Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol. 104 (1991) 765-767
5. Cunha F.Q., Pool S., Lorenzetti B.B., and Ferreira S.H. The pivotal role of TNF-α in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 107 (1992) 660-664
6. Cunha T.M., Verri Jr. W.A., Silva J.S., Poole S., Cunha F.Q., and Ferreira S.H. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc. Natl. Acad. Sci. 102 5 (2005) 1755-1760
7. De Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174 (1991) 1209-1220
8. Fiorentino D.F., Bond M.W., and Mosmann T.R. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170 (1989) 2081-2095
9. Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., and O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146 10 (1991) 3444-3451
10. Flatters S.J., Fox A.J., and Dickenson A.H. Nerve injury alters the effects of interleukin-6 on nociceptive transmission in peripheral afferents. Eur. J. Pharmacol. 484 2-3 (2004) 183-191
11. Henderson B., and Poole S. Modulation of cytokine function: therapeutic application. In: August L.J.T., Anders M.W., and Murad F. (Eds). Advances in Pharmacology vol. 25 (1994), Academic Press, London 53-115
12. Howard M., and O'Garra A. Biological properties of interleukin-10. Immunol. Today 13 (1992) 198-200
13. Jenkins J.K., Malyak M., and Arend W.P. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphokine Cytokine Res. 13 1 (1994) 47-54
14. Johnston I.N., Milligan E.D., Wieseler-Frank J., Frank M.G., Zapata V., Campisi J., Langer S., Martin D., Green P., Fleshner M., Leinwand L., Maier S.F., and Watkins L.R. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J. Neurosci. 24 33 (2004) 7353-7365
15. Kanaan S.A., Saadé N.E., Haddad J.J., Abdelnour A.M., Atweh S.F., Jabbur S.J., and Safieh-Garabedian B. Endotoxin-induced local inflammation and hyperalgesia in rats and mice: a new model for inflammatory pain. Pain 66 (1996) 373-379
16. Kanaan S.A., Poole S., Saadé N.E., Jabbur S.J., and Safieh-Garabedian B. Interleukin-10 reduces the endotoxin-induced hyperalgesia in mice. J. Neuroimmunol. 86 (1998) 142-150
17. Kanaan S.A., Saadé N.E., Karam M.C., Jabbur S.J., Khansa H., and Jurjus A.R. Hyperalgesia and upregulation of cytokines and nerve growth factor by cutaneous leishmaniasis in mice. Pain 85 (2000) 447-482
18. Kane M.M., and Mosser D.M. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166 2 (2001) 1141-1147
19. Karam M., Hamdan H., Abi Chedid N., Bodman-Smith K., Reynolds J.L., and Baroody G. Leishmania major: low infection dose causes short-lived hyperalgesia and cytokines up-regulation in mice. Exp. Parasitol. 113 3 (2006) 168-173
20. Kast R.E., and Altschuler E.L. Combination of bupropion, paroxetine and quetiapine as adjuvant treatment for multiple myeloma. Med. Hypotheses 62 5 (2004) 817-818
21. Kopp S., Alstergren P., Ernestam S., Nordahl S., Morin P., and Bratt J. Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis. Cells Tissues Organs 180 1 (2005) 22-30
22. Kubba R., EL-Hassan A.M., Al-Gindan Y., Omer A.H.S., Bushra M., and Kutty M.K. Peripheral nerve involvement in cutaneous leishmaniasis (Old World). Int. J. Dermatol. 26 (1987) 527-531
23. Malcangio M., Bowery N.G., Flower R.J., and Perretti M. Effect of interleukin-1β on the release of substance P from rat isolated spinal cord. Eur. J. Pharmacol. 299 (1996) 113-118
24. Mariana L.V., Marques J.B., Moreira C.A., Rocha F.A.C., Ferreira S.H., Poole S., Cunha F.Q., and Ribeiro R.A. Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats. J. Pharmacol. Exp. Ther. 304 1 (2003) 102-108
25. Milligan E.D., Langer S.J., Sloane E.M., He L., Wieseler-Frank J., O'Connor K., Martin D., Forsayeth J.R., Maier S.E., Johnson K., Chavez R.A., Leinwand L.A., and Watkins L.R. Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur. J. Neurosci. 21 8 (2005) 2136-2148
26. Moore K.W., Vieira P., Fiorentino D.F., Trounstine M.L., Khan T.A., and Mosmann T.R. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1. Science 248 (1990) 1230-1234
27. Newton B., Kuitert L.M.E., Bergmann M., Adcock I.M., and Barnes P.J. Evidence for involvement of NF-KB in the transcriptional control of COX-2 gene expression by IL-1β. Biochem. Biophys. Res. Commun. 237 (1997) 28-32
28. Niiro H., Otsuka T., Tanabe T., Hara S., Kuga S., Nemoto Y., Tanaka Y., Nakashima H., Kitajima S., Abe M., et al. Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: its underlying mechanism in comparison with interleukin-4. Blood 85 12 (1995) 3736-3745
29. Niiro H., Otsuka T., Izuhara K., Yamaoka K., Ohshima K., Tanabe T., Hara S., Nemoto Y., Tanaka Y., Nakashim H., and Niho Y. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 89 5 (1997) 1621-1628
30. Obreja O., Biasio W., Andratsch M., Lips K.S., Rathee P.K., Ludwig A., Rose-John S., and Kress M. Fast modulation of heat-activated ionic current by proinflammatory interleukin 6 in rat sensory neurons. Brain 128 Pt 7 (2005) 1634-1641
31. Oka T., Oka K., Hosoi M., and Hori T. Intracerebroventricular injection of interleukin-6 induces thermal hyperalgesia in rats. Brain Res. 692 (1995) 123-128
32. Opal S.M., and DePalo V.A. Anti-inflammatory cytokines. Chest 117 4 (2000) 1162-1172
33. Oswald I., Gazzinelli R., Sher A., and James S. IL-10 synergizes with IL-4 and transforming growth factor-b to inhibit macrophage cytotoxic activity. J. Immunol. 148 11 (1992) 3578-3582
34. Poole S., Cunha F.Q., Selkirk S., Lorenzetti B.B., and Ferreira S.H. Cytolike-mediated inflammatory hyperalgesia limited by interleukin-10. Br. J. Pharmacol. 115 (1995) 684-688
35. 2 receptors, tumour necrosis factor α and inflammatory hyperalgesia. Br. J. Pharmacol. 126 (1999) 649-656
36. Saade N.E., Nasr I.W., Massaad C.A., Safieh-Garabedian B., Jabbur S.J., and Kanaan S.A. Modulation of ultraviolet-induced hyperalgesia and cytokine upregulation by interleukins 10 and 13. Br. J. Pharmacol. 131 7 (2000) 1317-1324
37. Sekikawa A., Fukui H., Fujii S., Nanakin A., Kanda N., Uenoyama Y., Sawabu T., Hisatsune H., Kusaka T., Ueno S., Nakase H., Seno H., Fujimori T., and Chiba T. Possible role of REG Ialpha protein in ulcerative colitis and colitic cancer. Gut 54 10 (2005) 1437-1444
38. Sommer C. Cytokines and neuropathic pain. In: Hansson P., Fields H., Hill R., and Marchettini P. (Eds). Neuropathic Pain: Pathophysiology and Treatment vol. 21 (2001), IASP Press, Seattle, WA 37-62
39. Van der Poll T., Jansen P.M., Montegut W.J., Braxton C.C., Calvano S.E., Stackpole S.A., Smith S.R., Swasnon S.W., Hack C.E., Lowry S.F., and Moldawer L.L. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J. Immunol. 158 (1997) 1971-1975
40. Watkins L.R., Maier S.F., and Goehler L.E. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63 (1995) 289-302
41. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110